Merus Labs International Inc announces the execution of a binding letter of intent between its wholly owned subsidiary and Methapharm Inc. for the licensing, registration, and distribution of specific pharmaceutical products and medical devices in Canada , on an exclusive basis.
Merus Labs announces execution of binding letter of intent for the licensing, registration and distribution of specific pharmaceutical products and medical devices in Canada